China Universal Asset Management Company’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$907K Buy
29,021
+5,121
+21% +$127K 0.05% 215
2026
Q1
$500K Buy
23,900
+1,954
+9% +$27.2K 0.04% 260
2025
Q4
$194K Buy
21,946
+2,444
+13% +$21.1K 0.01% 346
2025
Q3
$164K Sell
19,502
-2,269
-10% -$15.4K 0.01% 345
2025
Q2
$111K Buy
21,771
+86
+0.4% +$213 0.01% 359
2025
Q1
$29.7K Sell
21,685
-1,092
-5% -$2.68K ﹤0.01% 447
2024
Q4
$70.4K Buy
22,777
+2,170
+11% +$10.1K 0.01% 426
2024
Q3
$159K Buy
20,607
+8,055
+64% +$76.9K 0.02% 319
2024
Q2
$108K Sell
12,552
-7,017
-36% -$54.2K 0.02% 298
2024
Q1
$155K Buy
19,569
+7,776
+66% +$83.3K 0.02% 321
2023
Q4
$117K Buy
11,793
+9,530
+421% +$82.7K 0.02% 264
2023
Q3
$25.5K Buy
2,263
+1,105
+95% +$6.74K 0.01% 286
2023
Q2
$3.85K Sell
1,158
-37
-3% -$133 ﹤0.01% 394
2023
Q1
$4.72K Buy
1,195
+299
+33% +$1.74K ﹤0.01% 369
2022
Q4
$6.5K Buy
+896
New +$6.3K ﹤0.01% 265

Other funds holding TNGX

China Universal Asset Management Company's TNGX Position: Q2 2026 in Review

China Universal Asset Management Company increased its Tango Therapeutics (TNGX) stake by 21% in Q2 2026, buying an estimated $127K and bringing the position to 29,021 shares worth $907K. The position accounts for 0.05% of the portfolio, ranked #215.

China Universal Asset Management Company first reported a position in TNGX in Q4 2022 and has held it in 15 quarters since. 24 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • China Universal Asset Management Company held 29,021 shares of Tango Therapeutics worth $907K as of Q2 2026.
  • China Universal Asset Management Company bought 5,121 Tango Therapeutics shares in Q2 2026, an estimated $127K.
  • Tango Therapeutics made up 0.05% of China Universal Asset Management Company's portfolio in Q2 2026, its #215 holding.
  • China Universal Asset Management Company first reported a position in Tango Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • 24 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.